BCAS3 Antibodies

Santa Cruz Biotechnology provides a broad selection of BCAS3 monoclonal antibodies for research focused on understanding BCAS3 protein functions. BCAS3 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BCAS3, or Breast Cancer Amplified Sequence 3, plays a significant role in regulating cell proliferation and survival, particularly in breast cancer. BCAS3 overexpression correlates with poor prognosis in breast cancer patients, highlighting its importance as a therapeutic target and potential biomarker. Understanding BCAS3 functionality continues to be crucial for advancing cancer research and developing targeted treatments. Researchers can utilize BCAS3 monoclonal antibodies to investigate cellular pathways, protein interactions, and expression patterns in various cancer models. Current studies focus on exploring BCAS3's role in tumor progression and metastasis. Ongoing research with BCAS3 monoclonal antibodies aims to uncover new therapeutic strategies for breast cancer treatment. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in their mission to advance scientific understanding and develop innovative cancer treatments.